Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sionna Therapeutics Inc.

    NASDAQ: SION · Real-Time Price · USD
    17.41
    1.57 (9.91%)
    At close: Jun 30, 2025, 3:59 PM
    17.35
    -0.34%
    After-hours: Jun 30, 2025, 05:51 PM EDT

    Sionna Therapeutics Statistics

    Share Statistics

    Sionna Therapeutics has 44.12M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 44.12M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4,177

    FTD / Avg. Volume

    n/a
    		 2.33%

    Short Selling Information

    The latest short interest is 2.83M, so 6.41% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.83M

    Short % of Shares Out

    n/a
    		 6.41%

    Short % of Float

    n/a
    		 10.79%

    Short Ratio (days to cover)

    n/a
    		 20.41

    Valuation Ratios

    The PE ratio is -17.2 and the forward PE ratio is -5.51. Sionna Therapeutics's PEG ratio is 1.17.

    PE Ratio

    n/a
    		 -17.2

    Forward PE

    n/a
    		 -5.51

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 12

    PB Ratio

    n/a
    		 -6.48

    P/FCF Ratio

    n/a
    		 -20.09

    PEG Ratio

    n/a
    		 1.17
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Sionna Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 14.49, with a Debt / Equity ratio of -0.06.

    Current Ratio

    n/a
    		 14.49

    Quick Ratio

    n/a
    		 14.49

    Debt / Equity

    n/a
    		 -0.06

    Debt / EBITDA

    n/a
    		 -0.14

    Debt / FCF

    n/a
    		 -0.18

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,504,585.37

    Employee Count

    n/a
    		 41

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 2.97, so Sionna Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.97

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 13.95

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 60.72

    Average Volume (20 Days)

    n/a
    		 179,432

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -70.56M

    Net Income

    n/a
    		 -61.69M

    EBITDA

    n/a
    		 -69.89M

    EBIT

    n/a
    		 -70.56M

    Earnings Per Share (EPS)

    n/a
    		 -1.45
    Full Income Statement

    Balance Sheet

    The company has 37.79M in cash and 9.75M in debt, giving a net cash position of 28.04M.

    Cash & Cash Equivalents

    n/a
    		 37.79M

    Total Debt

    n/a
    		 9.75M

    Net Cash

    n/a
    		 28.04M

    Retained Earnings

    n/a
    		 -181.09M

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -52.79M and capital expenditures -27K, giving a free cash flow of -52.81M.

    Operating Cash Flow

    n/a
    		 -52.79M

    Capital Expenditures

    n/a
    		 -27K

    Free Cash Flow

    n/a
    		 -52.81M

    FCF Per Share

    n/a
    		 -1.24
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SION does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SION is $32, which is 83.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $32

    Price Target Difference

    n/a
    		 83.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist